The targeting vector is designed to insert a loxP site upstream of exons 4 and an FRT-flanked neomycin resistance (neo) cassette, followed by a second loxP site downstream of exon 5. Flp-mediated recombination removed the FRT-flanked neo cassette. (J:101977)